CLINICAL_TRIALS
trial_result
· 2015-05-20
Clinical Trial Update: Study of RAD001 in Adenoid Cystic Carcinoma [Phase 2]
Summary
A Phase 2 study of RAD001 (everolimus) for Adenoid Cystic Carcinoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Seoul National University Hospital | Conditions: Adenoid Cystic Carcinoma | Phase 2 | Status: COMPLETED